Introduction: the objective was to study the place of endoscopic surgery in the management of benign prostatic hyperplasia. Materials and methods: This was a retrospective and prospective descriptive study ranging from July 1, 2020 to November 30, 2021, i.e. 17 months, carried out in the urology department of the University hospital Pr Bocar Sidy Sall at Kati. Were included, all patients who had undergone surgical treatment of benign prostatic hyperplasia by endoscopic route during the study period. The data was entered and analyzed using software: Word 2019, Excel 2019 and SPSS version 25.0. Epi info version 3.53. Result: we collected 70 cases of endoscopic surgery for the management of benign prostatic hyperplasia in 17 months. The age group of 60-70 was the most represented with 42.9% of cases. Lower tract urinary symptoms were the most common reason for consultation, at 68.6%. We performed 21 cases of monopolar TURP, i.e. 30% of cases; 39 cases of bipolar TURP, i.e. in 55.7%; 10 cases of transurethral bipolar vaporization of the prostate or 14.3% of cases. The postoperative course was simple in 92.9% of cases. The probe was removed between D1 and D3 in 62.9% of cases. The average duration of hospitalization was 1.5 days with extremes of 1 and 15 days. Conclusion: Endoscopic surgery for benign prostatic hyperplasia remains the reference treatment in the surgical management of BPH. It is a technique that has proven its effectiveness. Bipolar transurethral vaporization of the prostate, monopolar and bipolar TURP have an important place in the management of BPH in our department.
Published in | International Journal of Clinical Urology (Volume 7, Issue 2) |
DOI | 10.11648/j.ijcu.20230702.14 |
Page(s) | 44-47 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Endoscopic Surgery, BPH, Bipolar TURP, Vaporization
[1] | Natal R. Place of surgical endoscopy in urology. Acta endoscopia 1975; 5: 187-189. |
[2] | Delongchamps B, Robert G, Descazeaud A, Cornue JN, Azzouzif AR, Haillot O and al. Treatment of BPH by electric endoscopic techniques and high adenomectomy. AFU CTMH literature review. Prog. Urol. 2012; 22: 73-79. |
[3] | Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS and al. Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction. BMC Geriatrics 2018; 18 (1): 15. |
[4] | Tan AH, Gilling PJ, Kennett KM, Fletcher H, Fraundorfer MR. Long-term results of high-power holmium laser vaporization (ablation) of the prostate. BJU Int 2003; 7: 707-709. |
[5] | Sinha MM, Pietropaolo A, Hameed BMZ, Gauhar V, Somani BK. Outcomes of bipolar TURP compared to monopolar TURP: A comprehensive literature review. Turk J Urol 2022; 48 (1): 1-10. |
[6] | Paulhac P, Desgrandchamps F, Teillac P, Le Duc A. Endoscopic treatment of benign prostatic hypertrophy. Encycl. Med. Chir. (urological surgical techniques) 1998; 13: 41-273. Paris. Ed Elsevier. |
[7] | Bucuras V, Bardan R. Bipolar vaporization of the prostate: is it ready for the primetime? Ther Adv Urol 2011; 3 (6): 257-261. |
[8] | Kassogue A, Diakite ML, Sissoko I, Sember A, Diallo MS, Sangare D, Togo P, Coulibaly S, Berthe H. Monopolar Transuretral Resection of Prostate in the Urology Department of the University Hospital Pr Bocar S SALL of Kati. International Journal of Clinical Urology 2023; 7 (1) 2023: 5-8. |
[9] | Abdelwahab O, Habous M, Aziz M, Sultan M, Farag M, Santucci R, Binsaleh S. Bipolar vaporization of the prostate may cause higher complication rates compared to bipolar loop resection: a randomized prospective trial. Int Urol Nephrol 2019; 51 (12): 2143-2148. |
[10] | Falahatkar S, Mokhtari G, Moghaddam KG, Asadollahzade A, Farzan A, Shahab E and al. Bipolar transurethral vaporization: a superior procedure in benign prostatic hyperplasia: a prospective randomized comparison with bipolar TURP. J Urol. 2014; 40 (3): 346-55. |
[11] | Lepage JY, Rivault O, Karam G, Malinovsky JM, Le Gouedec G, Cozian A and al. Anesthesia and prostate surgery. Ann. Fr. Anesth. Reanim. 2005; 24 (4): 397-411. |
[12] | Issa MM. Technological advances in transurethral resection of the prostate: bipolar versus monopolar TURP. J Endourol 2008; 22 (8): 1587-1595. |
[13] | Ndiath A, Sarr A, Diaw EM, Sow O, Ndiaye M, Sine B, and al. Morbi-mortality of bipolar transurethral resection of the prostate at the Urology Andrology Department of Aristide Le Dantec Hospital in Dakar. PAMJ - Clinical Medicine 2021; 5 (75): 1-6. |
[14] | Cornu JN, Ahyai S, Bachmann A, Rosette J, Gilling P, Gratzke C and al. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. Eur Urol 2015; 67 (6): 1066-1096. |
[15] | Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of trans urethral resection of the prostate (TURP)- incidence, management, and prevention. Eur Urol. 2006; 50 (5): 969-980. |
[16] | Tang Y, Li J, Pu C, Bai YJ, Yuan H, Wei Q and al. Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: a systematic review and meta-analysis. J Endourol 2014; 28 (9): 1107-14. |
[17] | Rabii R, Heddat A, Doumer A, Seffar A. Ambulatory prostate surgery by turis bipolar photo-vaporization: first experience in Africa for 504 patients. Prog. Urol. 2018; 28 (13): 737-738. |
APA Style
Amadou Kassogue, Alassane Bouare, Idrissa Sissoko, Moussa Salifou Diallo, Daouda Sangare, et al. (2023). Endoscopic Surgery for Benign Prostatic Hyperplasia in the Urology Department of the Pr Bocar Sidy SALL University Hospital of Kati. International Journal of Clinical Urology, 7(2), 44-47. https://doi.org/10.11648/j.ijcu.20230702.14
ACS Style
Amadou Kassogue; Alassane Bouare; Idrissa Sissoko; Moussa Salifou Diallo; Daouda Sangare, et al. Endoscopic Surgery for Benign Prostatic Hyperplasia in the Urology Department of the Pr Bocar Sidy SALL University Hospital of Kati. Int. J. Clin. Urol. 2023, 7(2), 44-47. doi: 10.11648/j.ijcu.20230702.14
AMA Style
Amadou Kassogue, Alassane Bouare, Idrissa Sissoko, Moussa Salifou Diallo, Daouda Sangare, et al. Endoscopic Surgery for Benign Prostatic Hyperplasia in the Urology Department of the Pr Bocar Sidy SALL University Hospital of Kati. Int J Clin Urol. 2023;7(2):44-47. doi: 10.11648/j.ijcu.20230702.14
@article{10.11648/j.ijcu.20230702.14, author = {Amadou Kassogue and Alassane Bouare and Idrissa Sissoko and Moussa Salifou Diallo and Daouda Sangare and Philippe Togo and Albacaye Sember and Drissa Cisse and Honore Berthe and Salia Coulibaly and Mamadou Lamine Diakite}, title = {Endoscopic Surgery for Benign Prostatic Hyperplasia in the Urology Department of the Pr Bocar Sidy SALL University Hospital of Kati}, journal = {International Journal of Clinical Urology}, volume = {7}, number = {2}, pages = {44-47}, doi = {10.11648/j.ijcu.20230702.14}, url = {https://doi.org/10.11648/j.ijcu.20230702.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcu.20230702.14}, abstract = {Introduction: the objective was to study the place of endoscopic surgery in the management of benign prostatic hyperplasia. Materials and methods: This was a retrospective and prospective descriptive study ranging from July 1, 2020 to November 30, 2021, i.e. 17 months, carried out in the urology department of the University hospital Pr Bocar Sidy Sall at Kati. Were included, all patients who had undergone surgical treatment of benign prostatic hyperplasia by endoscopic route during the study period. The data was entered and analyzed using software: Word 2019, Excel 2019 and SPSS version 25.0. Epi info version 3.53. Result: we collected 70 cases of endoscopic surgery for the management of benign prostatic hyperplasia in 17 months. The age group of 60-70 was the most represented with 42.9% of cases. Lower tract urinary symptoms were the most common reason for consultation, at 68.6%. We performed 21 cases of monopolar TURP, i.e. 30% of cases; 39 cases of bipolar TURP, i.e. in 55.7%; 10 cases of transurethral bipolar vaporization of the prostate or 14.3% of cases. The postoperative course was simple in 92.9% of cases. The probe was removed between D1 and D3 in 62.9% of cases. The average duration of hospitalization was 1.5 days with extremes of 1 and 15 days. Conclusion: Endoscopic surgery for benign prostatic hyperplasia remains the reference treatment in the surgical management of BPH. It is a technique that has proven its effectiveness. Bipolar transurethral vaporization of the prostate, monopolar and bipolar TURP have an important place in the management of BPH in our department.}, year = {2023} }
TY - JOUR T1 - Endoscopic Surgery for Benign Prostatic Hyperplasia in the Urology Department of the Pr Bocar Sidy SALL University Hospital of Kati AU - Amadou Kassogue AU - Alassane Bouare AU - Idrissa Sissoko AU - Moussa Salifou Diallo AU - Daouda Sangare AU - Philippe Togo AU - Albacaye Sember AU - Drissa Cisse AU - Honore Berthe AU - Salia Coulibaly AU - Mamadou Lamine Diakite Y1 - 2023/07/31 PY - 2023 N1 - https://doi.org/10.11648/j.ijcu.20230702.14 DO - 10.11648/j.ijcu.20230702.14 T2 - International Journal of Clinical Urology JF - International Journal of Clinical Urology JO - International Journal of Clinical Urology SP - 44 EP - 47 PB - Science Publishing Group SN - 2640-1355 UR - https://doi.org/10.11648/j.ijcu.20230702.14 AB - Introduction: the objective was to study the place of endoscopic surgery in the management of benign prostatic hyperplasia. Materials and methods: This was a retrospective and prospective descriptive study ranging from July 1, 2020 to November 30, 2021, i.e. 17 months, carried out in the urology department of the University hospital Pr Bocar Sidy Sall at Kati. Were included, all patients who had undergone surgical treatment of benign prostatic hyperplasia by endoscopic route during the study period. The data was entered and analyzed using software: Word 2019, Excel 2019 and SPSS version 25.0. Epi info version 3.53. Result: we collected 70 cases of endoscopic surgery for the management of benign prostatic hyperplasia in 17 months. The age group of 60-70 was the most represented with 42.9% of cases. Lower tract urinary symptoms were the most common reason for consultation, at 68.6%. We performed 21 cases of monopolar TURP, i.e. 30% of cases; 39 cases of bipolar TURP, i.e. in 55.7%; 10 cases of transurethral bipolar vaporization of the prostate or 14.3% of cases. The postoperative course was simple in 92.9% of cases. The probe was removed between D1 and D3 in 62.9% of cases. The average duration of hospitalization was 1.5 days with extremes of 1 and 15 days. Conclusion: Endoscopic surgery for benign prostatic hyperplasia remains the reference treatment in the surgical management of BPH. It is a technique that has proven its effectiveness. Bipolar transurethral vaporization of the prostate, monopolar and bipolar TURP have an important place in the management of BPH in our department. VL - 7 IS - 2 ER -